FDA Plans To Rely On Non-U.S. Regulators In Global Drug Quality Initiative
This article was originally published in The Tan Sheet
Executive Summary
FDA restructures its staff as it prepares for new U.S.-EU mutual reliance activities to enhance pharmaceutical quality, but it offers few details on upcoming plans.